Article Information
History
- June 3, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Maximilian Schönung1,2,
- Mark Hartmann1,3,
- Stephen Krämer1,2,4,
- Sina Stäble1,
- Mariam Hakobyan1,2,
- Emely Kleinert1,
- Theo Aurich5,6,
- Defne Cobanoglu1,7,
- Florian H. Heidel8,9,
- Stefan Fröhling10,
- Michael D. Milsom5,6,
- Matthias Schlesner4,
- Pavlo Lutsik11 and
- Daniel B. Lipka1,12,*
- 1Section Translational Cancer Epigenomics, Division Translational Medical Oncology, German Cancer Research Center (DKFZ) & National Center for Tumor Diseases (NCT), Heidelberg, Germany
- 2Faculty of Biosciences, Heidelberg University, Heidelberg, Germany
- 3Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- 4Biomedical Informatics, Data Mining and Data Analytics, Faculty of Applied Computer Science and Medical Faculty, University of Augsburg, Augsburg, Germany
- 5Division of Experimental Hematology, German Cancer Research Center (DKFZ), Heidelberg, Germany
- 6Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany
- 7Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany
- 8Innere Medizin C, Universitätsmedizin Greifswald, Greifswald, Germany
- 9Leibniz Institute on Aging, Fritz-Lipmann-Institute, Jena, Germany
- 10Division Translational Medical Oncology, German Cancer Research Center (DKFZ) & National Center for Tumor Diseases (NCT), Heidelberg, Germany
- 11Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany
- 12Faculty of Medicine, Otto-von-Guericke-University, Magdeburg, Germany
- ↵*Correspondence to: Daniel B. Lipka, Section Translational Cancer Epigenomics, Division Translational Medical Oncology, German Cancer Research Center (DKFZ) & National Center for Tumor Diseases (NCT), Heidelberg, Germany. Email: d.lipka{at}dkfz.de